Patents by Inventor Dominic SINIBALDI

Dominic SINIBALDI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF CARDIOMETABOLIC DISEASE WITH INHIBITORS OF TYPE I INTERFERON SIGNALLING
    Publication number: 20240158519
    Abstract: The disclosure relates to methods for the treatment of, or for reducing the risk for development of, a cardiometabolic in a patient using an inhibitor of type I IFN signalling.
    Type: Application
    Filed: December 22, 2023
    Publication date: May 16, 2024
    Inventors: Dominic SINIBALDI, Wendy WHITE, Michael SMITH, Kerry CASEY, Gabor ILLEI
  • TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20220348669
    Abstract: The disclosure relates to methods and compositions for the treatment of lupus nephritis. Specifically, the disclosure relates to methods comprising administering to a subject a type I IFN receptor inhibitor.
    Type: Application
    Filed: April 22, 2022
    Publication date: November 3, 2022
    Applicant: AstraZeneca AB
    Inventors: Catharina LINDHOLM, Yen Lin CHIA, Rajendra TUMMALA, Lorin ROSKOS, Joachim ALMQUIST, Tomas ROUSE, Teodora TRASIEVA, Wendy WHITE, Dominic SINIBALDI, Madhu RAMASWAMY, Paul NEWCOMBE
  • TYPE I INTERFERON-MEDIATED DISORDERS
    Publication number: 20220162325
    Abstract: The invention provides methods of identifying, diagnosing, treating, and monitoring or prognosing progression of type I IFN-mediated disease or disorder in subjects. The present invention further relates to methods of identifying candidate therapeutic agents for treating a type I interferon-mediated disease or disorder.
    Type: Application
    Filed: February 14, 2020
    Publication date: May 26, 2022
    Inventors: Kerry CASEY, Dominic SINIBALDI, Michael SMITH, Miguel SANJUAN